During the 12th Five Year Plan, the Indian Government has planned to set-up an All India Institute of Homoeopathy, Homoeopathic Manufacturing Public Sector undertaking etc. However, the 12th Plan is yet to be approved by the competent authority. This is revealed by Minister of State for Health & Family Welfare Shri S. Gandhiselvan in the Lok Sabha last week.
During the 11th Five Year Plan Period, the Indian Government has taken following important steps to promote and popularise homoeopathic treatment and medicines:
· The Homoeopathic system has been supported through Centrally Sponsored and Central Sector Schemes of the Department of AYUSH.
· The Cabinet has approved for establishing of a North Eastern Institute of Ayurveda and Homoeopathy at shillong, Meghalaya at a cost of Rs.71.81 crores.
· Under Graduate (UG) and post Graduate (PG) seats at National Institute of Homoeopathy (Kolkata) have been increased from 50 to 93; and 18 to 36 respectively. In addition PG specialization in three more subjects have been added.
· Homoeopathic Units have been established in Primary Health Centre and Community Health Centre under National Rural Health Mission (NRHM).
· National campaign on Mother and Child Health has been launched and the awareness of Homoeopathic System is done through the print and electronic media under Information, Education and Communication Programme and through AROGYA Melas.
Important achievements regarding research and developments in the Homoeopathy have been as follows:
A. Central Council for Research in Homoeopathy (CCRH)
i) CCRH has undertaken 23 Clinical Research studies on diseases like rhinitis, acute otitis media, chronic sinusitis, diarrhea, Urolithiasis, Vitiligo etc. The results have been published in various international and national journals.
ii) Verification studies of 34 drugs have been completed. Clinical Verified data of 52 drugs, out of which 24 drugs of indigenous origin has been published.
iii) Drug Proving on 23 drugs completed, out of which four are new drugs and data of 14 drugs published.
iv) Pharmacopoeial standards of 40 drugs have been worked out for inclusion in Homoeopathic Pharmacopoeia of India. 12 fundamental research studies with Institutes of excellence have been completed and 11 research articles published.
B. Collaborative Research of CCRH
Studies under Collaboration with Institutes of Excellence have shown evidence of biological activity of Homoeopathic medicine in in-vitro and animal model in the clinical conditions of Japanese Encephalitis (School of Tropical Medicine), Cancer (Bose Institute), Kidney stone (University of Madras) and diabetes (University of Madras) and result have been published in Indian Journal of Research in Homoeopathy (IJRH) and International journals.
C. Extra Mural Research
Studies conducted in Extra Mural Research have resulted in generation of evidence-based support in favour of efficacy of homoeopathic drugs in diseases like autoimmune thyroiditis, Diarrhea, Learning disabilities, Leprosy, ovarian cyst, Uterine Fibroid, scabies etc. Studies undertaken to investigate the anti-oxidant effect, anti-cancer potential, neuro-protective effects and effects on cardiac neuropathy of the homeopathic drugs in animal models have yielded positive results.